phase readout
saveNCT04691154: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
ACTIVE_NOT_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Liquidia Technologies, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Lung Diseases
view source ↗
comments(0)
5-min edit window · permanent after that